Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Gains from Sales and Divestitures (2017 - 2024)

Historic Gains from Sales and Divestitures for Aethlon Medical (AEMD) over the last 6 years, with Q4 2024 value amounting to $76943.0.

  • Aethlon Medical's Gains from Sales and Divestitures changed N/A to $76943.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $76943.0, marking a year-over-year change of. This contributed to the annual value of $34378.0 for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Aethlon Medical's Gains from Sales and Divestitures stood at $76943.0.
  • In the past 5 years, Aethlon Medical's Gains from Sales and Divestitures ranged from a high of $76943.0 in Q4 2024 and a low of $27602.0 during Q2 2024